SYNCHRON

Company Snapshot

Founded: 2012

Entity Type: Private

Region: U.S.

Headquarter: New York, U.S.

Key Geographics: U.S.

Corporate Address: Brooklyn, New York 11205, U.S. Web.: www.synchron.com

Company Overview

Synchron was founded in 2012 with headquarters in U.S. The company also has a research and development facility located in Melbourne, Australia. The company designs and develops implantable neural interfaces for treating paralysis. Potential applications for treating and diagnosing nervous system include epilepsy, depression, Parkinson’s and hypertension.

SYNCHRON In Reports

Brain-Computer Interface: Global Markets

BCC Research Market Analyst says global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029.

Neuroprosthetics: Technologies and Global Markets

BCC Research's report on neuroprosthetics technologies provides a comprehensive overview of the global market for neuroprosthetics, including current and projected market forecasts for the period 2023-2028.

View All Reports

Company's Business Segments

Brain Computer Interface : This segment includes Developing Implantable Neurotechnology to unlock the Brain and Solve unmet Medical Needs.

Applications/End User Industries

Neurotechnology
Brain Computer Interface
Neuroprosthesis
Neuromodulation
Neuromonitoring

Medtech
Biotech
Machine Learning
Signal Processing
Life Sciences